open access

Vol 82, No 5 (2011)
ARTICLES
Get Citation

Genetic variability of endothelin-1 system in gestational hypertension and preeclampsia

Agnieszka Seremak-Mrozikiewicz, Magdalena Barlik, Michał Perlik, Grażyna Kurzawińska, Krzysztof Drews
Ginekol Pol 2011;82(5).

open access

Vol 82, No 5 (2011)
ARTICLES

Abstract

Summary Introduction: Recently much attention has been focused on endothelin-1 (ET-1) and endothelin-1 converting enzyme (ECE-1) gene polymorphisms and connected changes in ET-1 concentration. Additionally, these processes have been shown to be possibly involved in preeclampsia susceptibility. The aim of this study was to evaluate the correlation between ET-1 (Lys198Asn) and ECE-1 (Thr341Ile) gene polymorphisms and the risk of gestational hypertension and preeclampsia. Material and methods: The study group consisted of 110 hypertensive (69 with gestational hypertension and 41 preeclamptic) pregnant women. The control group included 150 healthy pregnant women. The frequency of investigated polymorphisms was examined by polymerase chain reaction and restriction fragment length polymorphism (PCR/RFLP) assay. Results: There were no statistically significant differences in genotype frequencies of ET-1 Lys198Asn and ECE-1 Thr341Ile gene polymorphic variants between hypertensive pregnant women and the control group. There were also no remarkable differences between GH and PE groups when compared to the controls. However, parallel presence of both Thr341Ile ECE-1 and Lys198Asn ET-1 variant localisation showed a higher occurrence rate of ECE-1 CT/ET-1 GT heterozygotic genotypes in the control group (5,3%) than in the whole study or GH and PE groups (0.9%, 1.4% and 0.0% respectively, p=ns). In preeclamptic women, the higher systolic blood pressure value was observed in GG Lys198Asn ET-1 genotype carriers (180.7 mmHg) than in patients with at least one mutated T allele (GT and TT) (167.3 mmHg, p=ns). The lowest blood pressure level was connected with the mutated TT Lys198Asn ET-1 genotype presence. Conclusions: Results of this study suggest lack of direct correlation of Lys198Asn ET-1 and Thr341Ile ECE-1 gene polymorphisms with risk of gestational hypertension and preeclampsia in the studied population of Polish women. High prevalence of ECE-1 CT/ET-1 GT heterozygote genotypes of both Thr341Ile ECE-1 and Lys198Asn ET-1 polymorphisms in healthy pregnant subjects compared to GH and PE groups suggests the protective role of mutated alleles in the development of PE. The carrier of mutated TT genotype of Lys198Asn ET-1 polymorphism is probably connected with lower systolic blood pressure level in preeclamptic women. Future studies are needed to establish the role of analysed polymorphisms in the etiology of gestational hypertension and preeclampsia.

Abstract

Summary Introduction: Recently much attention has been focused on endothelin-1 (ET-1) and endothelin-1 converting enzyme (ECE-1) gene polymorphisms and connected changes in ET-1 concentration. Additionally, these processes have been shown to be possibly involved in preeclampsia susceptibility. The aim of this study was to evaluate the correlation between ET-1 (Lys198Asn) and ECE-1 (Thr341Ile) gene polymorphisms and the risk of gestational hypertension and preeclampsia. Material and methods: The study group consisted of 110 hypertensive (69 with gestational hypertension and 41 preeclamptic) pregnant women. The control group included 150 healthy pregnant women. The frequency of investigated polymorphisms was examined by polymerase chain reaction and restriction fragment length polymorphism (PCR/RFLP) assay. Results: There were no statistically significant differences in genotype frequencies of ET-1 Lys198Asn and ECE-1 Thr341Ile gene polymorphic variants between hypertensive pregnant women and the control group. There were also no remarkable differences between GH and PE groups when compared to the controls. However, parallel presence of both Thr341Ile ECE-1 and Lys198Asn ET-1 variant localisation showed a higher occurrence rate of ECE-1 CT/ET-1 GT heterozygotic genotypes in the control group (5,3%) than in the whole study or GH and PE groups (0.9%, 1.4% and 0.0% respectively, p=ns). In preeclamptic women, the higher systolic blood pressure value was observed in GG Lys198Asn ET-1 genotype carriers (180.7 mmHg) than in patients with at least one mutated T allele (GT and TT) (167.3 mmHg, p=ns). The lowest blood pressure level was connected with the mutated TT Lys198Asn ET-1 genotype presence. Conclusions: Results of this study suggest lack of direct correlation of Lys198Asn ET-1 and Thr341Ile ECE-1 gene polymorphisms with risk of gestational hypertension and preeclampsia in the studied population of Polish women. High prevalence of ECE-1 CT/ET-1 GT heterozygote genotypes of both Thr341Ile ECE-1 and Lys198Asn ET-1 polymorphisms in healthy pregnant subjects compared to GH and PE groups suggests the protective role of mutated alleles in the development of PE. The carrier of mutated TT genotype of Lys198Asn ET-1 polymorphism is probably connected with lower systolic blood pressure level in preeclamptic women. Future studies are needed to establish the role of analysed polymorphisms in the etiology of gestational hypertension and preeclampsia.
Get Citation

Keywords

preeclampsia, gestational hypertension, endothelin-1, endothelin-1 converting enzyme, Genetic polymorphism

About this article
Title

Genetic variability of endothelin-1 system in gestational hypertension and preeclampsia

Journal

Ginekologia Polska

Issue

Vol 82, No 5 (2011)

Bibliographic record

Ginekol Pol 2011;82(5).

Keywords

preeclampsia
gestational hypertension
endothelin-1
endothelin-1 converting enzyme
Genetic polymorphism

Authors

Agnieszka Seremak-Mrozikiewicz
Magdalena Barlik
Michał Perlik
Grażyna Kurzawińska
Krzysztof Drews

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl